Advances in Alzheimer’s Disease: From Metabolic Dysregulation to Molecular Pathophysiology and Therapeutics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 22
Special Issue Editor
Interests: Alzheimer's disease; brain metabolism; obesity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Alzheimer’s disease (AD) is increasingly understood as a disorder at the crossroads of metabolism, inflammation, and neurodegeneration. This Special Issue welcomes cutting-edge contributions that illuminate how metabolic dysregulation, including neuroenergetic failure, brain insulin resistance, adipokine signaling, mitochondrial/redox imbalance, and peripheral–central crosstalk, drives the molecular pathophysiology of AD and reveals actionable therapeutic opportunities.
We invite original research, short communications, systematic reviews/meta-analyses, and perspectives spanning molecular mechanisms and multi-omics (genomics, epigenomics, proteomics, metabolomics, lipidomics); biomarkers and imaging (fluid, neuroimaging, digital); neuroimmune interfaces (microglia/astroglia, cytokine networks), vascular–metabolic pathways, and gut–brain or endocrine axes; sex differences and life-course factors; and translational pipelines linking targets to interventions. Therapeutic domains include small molecules, biologics, gene and cell strategies, nutraceuticals, lifestyle/dietary modulators, and data-driven approaches (AI/ML for target discovery, patient stratification, and treatment response).
We particularly encourage studies that (i) connect peripheral metabolic states to central mechanisms; (ii) integrate multi-scale data to uncover causal pathways; (iii) propose or validate biomarkers aligned with clinical endpoints; and (iv) demonstrate mechanistic engagement of targets. Methodology papers that enhance reproducibility, transparency, and open science (e.g., standardized pipelines, sharable code/datasets, and reporting checklists) are also welcome.
Our goal is to assemble a forward-looking collection that maps the continuum from metabolic dysregulation to molecular insight to therapeutic translation, accelerating progress toward meaningful prevention and treatment in AD. Join us in charting the next wave of discovery and innovation.
Dr. Pedro Cisternas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- metabolic dysregulation
- brain insulin resistance
- neuroenergetics
- mitochondrial dysfunction
- adipokines
- neuroinflammation
- gut–brain axis
- multi-omics biomarkers
- therapeutics and precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
